Abiopharma

🔍 Van Nieuwenhuyse Rick (Executive)

Company: Contango Silver & Gold Inc. (CTGO)

Report Date: 2026-04-02

Detailed Transactions and Holdings:

• Acquired 34,000 shares of Common Stock, par value $0.01 (Direct)
  Date: 2026-04-02 | Code: A | equity_swap_involved: false | shares_owned_after: 551,140.00 | transaction_form_type: 4 | Footnotes: F1, F1, F1
• Acquired 57,500 shares of Stock Option (right to buy) at $18.55 per share (Derivative)
  Date: 2026-04-02 | Code: A | Expires: 2031-04-02 | equity_swap_involved: false | shares_owned_after: 57,500.00 | transaction_form_type: 4 | Footnotes: F2

Footnotes:

• F1: On April 2, 2026, the reporting person was granted 34,000 shares of restricted stock, which vest equally over two years with half vesting on April 2, 2027 and the remaining half vesting on April 3, 2028.
• F2: On April 2, 2026, the reporting person was granted 57,500 stock options that over two years with half vesting on April 2, 2027 and the remaining half vesting on April 3, 2028.